Academic institutions grant commercial license for CRISPR-based SHERLOCK diagnostic technology in developed world
Rights are protected for broad use in developing world and for public health needs.
Rights are protected for broad use in developing world and for public health needs.
MIT-led team uses nanoparticles to deliver genes into plant chloroplasts.
Overactive repair system promotes cell death following DNA damage by certain toxins, study shows.
The need to produce just the right amount of protein is behind the striking uniformity of sizes.
CRISPR team harnesses new Cas12b enzyme for use in eukaryotic cells, adding to the CRISPR toolbox.
Whitehead Institute researchers uncover a group of introns in yeast that possess surprising stability and function.
Computer program can translate a free-form 2-D drawing into a DNA structure.
Researchers develop a method to investigate how bacteria respond to starvation and to identify which proteins bind to the “magic spot” — ppGpp.
Researchers refine a method to quantify protein production, show that the precision with which bacteria and eukaryotes tune their gene expression is remarkably similar.
It’s not quite the Ant-Man suit, but the system produces 3-D structures one thousandth the size of the originals.
A new study linking RNA processing to DNA repair may open new avenues to cancer therapy.
Enzyme can target almost half of the genome’s “ZIP codes” and could enable editing of many more disease-specific mutations.
Biological engineers design RNA circuits that enable precise control over the dose of therapeutic protein a patient receives.
Cryptography techniques to screen synthetic DNA could help prevent the creation of dangerous pathogens, argues Professor Kevin Esvelt.
Researchers identify an essential protein that helps enzymes relax overtwisted DNA so each strand can be copied during cell division.